| Products |
|
|
 |
| Contact Us |
 |
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China |
 |
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621 |
 |
Fax: +86-531-88817925 |
 |
Zip Code: 250101 |
 |
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com |
|
|
|
| Cell Signaling Pathway Inhibitors |
Now Position:Home > Products > Cell Signaling Pathway Inhibitors < Inhibitors of VEGFR pathways |
|
| Foretinib; GSK1363089; XL880(CAS:849217-64-7, 1332889-22-1 (H2O)) |
 |
|
|
Product No.
|
|
TP1056A
|
|
Name
|
|
Foretinib
|
|
Synonyms
|
|
GSK1363089, XL880
|
|
CAS Number
|
|
849217-64-7, 1332889-22-1 (H2O)
|
|
Structure
|
|
|
|
Brief Description
|
|
XL880 (GSK1363089, EXEL-2880) is an ATP-competitive inhibitor of MET and KDR with IC50 of 0.4 nM and 0.9 nM, respectively.
|
|
Purity
|
|
>99%
|
|
Package
|
|
5mg, 10mg, 20mg, 50mg
|
|
|
|
|
|
|
